Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T21:15:08.858Z Has data issue: false hasContentIssue false

Risperidone induced periorbital oedema

Published online by Cambridge University Press:  13 June 2014

Vikrant Bajaj*
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
Ankur Srivastava
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
Somnath Sengupta
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
Saurabh Mehrotra
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
Shaveta Vedi
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
Prashant Pathak
Affiliation:
Institute of Human Behaviour & Allied Sciences (IHBAS), Dilshad Garden, Delhi, India
*
*Correspondence E-mail: drvikrantbajaj@yahoo.co.in
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Antipsychotic medications are associated with adverse cutaneous reactions (ACRs) in approximately 2–3% of patients. We present three cases of possible risperidone induced periorbital oedema in the absence of any other systemic or local cause responsible for the oedema. The development of periorbital oedema after the initiation of risperidone therapy, and disappearance after the discontinuation of this drug, suggests a possible causal relationship between periorbital oedema and risperidone. To our knowledge, there are very few reports of risperidone therapy and development of periorbital oedema. Risperidone is a valid and effective choice amongst antipsychotic medications, but these cases call for caution regarding ACRs at the time of prescribing.

Information

Type
Case reports
Copyright
Copyright © Cambridge University Press 2010